Abstract:Objectives To compare the differences in clinical manifestations,airway inflammation and airway inflammatory mediators between CVA responsive and unresponsive to bronchodilator therapy.Methods Seventy-two patients with CVA were divided into two subgroups according to their different responses to the treatment of bronchodilators,CVA responsive group(55 cases) and unresponsive group(17 cases).Control groups included 26 classic asthmatic patients and 26 healthy volunteers respectively.Differences in clinical manifestation,cough reflex sensitivity to inhaled capsaicin,lung function parameters,airway hyperresponsiveness,total cell number or differentials in induced sputum,and levels of histamine,prostaglandin D2,interleukin-5 and eosinophil cationic protein in supernatants of induced sputum were compared among all the groups.Results CVA responsive to bronchodilator therapy accounted for 76% and unresponsive accounted for 24%.Cough threshold logC5 was lower in the former than that in the latter(P0.05).Lung function parameters such as FEV1,FVC,FEV1/FVC,MMEF and PD20FEV1 tended to be decrease in CVA responsive to bronchodilator therapy when compared with the unresponders,even though the difference was not significant.CVA responsive to bronchodilator therapy presented with a higher percentage of eosinophils in induced sputum(P0.05),higher levels of prostaglandin D2(P0.01) and eosinophil cationic protein(P0.01) in the supernatant of induced sputum than the unresponders did.Moreover,there was an apparent positive correlation between changes in cough symptom score and the percentage of eosinophils(r=0.254,P=0.036) in induced sputum,prostaglandin D2(r=0.422,P=0.007),histamine(r=0.365,P=0.020) or eosinophil cationic protein(r=0.371,P=0.020) in the supernatant of induced sputum after one week treatment with bronchodilators in the responders.A negative correlation was also found between changes in cough symptom score and cough threshold logC5 in these patients(r=-2.064,P=0.025).Conclusion CVA may be divided into two subgroups according to the response to bronchodilator therapy,which possibly has different underlying mechanisms for cough.The varied bronchoconstriction caused by inflammatory mediators in airway may be crucial in determining the efficacy of bronchodilator therapy.

Cough and cough hypersensitivity as treatable traits of asthma

Cough hypersensitivity and chronic cough

Upper-Airway Cough Syndrome with Latent Eosinophilic Bronchitis

Cough Hypersensitivity in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Diagnosis and management of cough-variant asthma

Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes

Airway Inflammation, Bronchial Hyperresponsiveness, and Anti-Asthma Therapy Responses in Cough Variant Asthma and Classic Asthma with FEV1%≥80% Predicted

Questionnaire Survey of Chronic Cough in Asthmatic Patients

Capsaicin-sensitive cough receptors in lower airway are responsible for cough hypersensitivity in patients with upper airway cough syndrome.

Cough Reflex Hypersensitivity as a Key Treatable Trait

Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China

A Prospective Study on the Causes of Chronic Cough

Cough Reflex Sensitivity And Airway Inflammation In Patients With Chronic Cough Due To Non-Acid Gastro-Oesophageal Reflux

CHANGES AND IMPLICATIONS OF COUGH SENSITIVITY IN UPPER AIRWAY COUGH SYNDROME

Comparative Study of Cough Variant Asthma and Cough Reflex Sensitivity

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children

From bench to bedside: The role of cough hypersensitivity in chronic cough

Comparative Study of Cough Variant Asthma Responsive and Unresponsive to Bronchodilator Treatment

Discrepancy Between Presumptive and Definite Causes of Chronic Cough

Cough and Eosinophilia

[Changes in the Spectrum and Frequency of Causes for Chronic Cough: a Retrospective Analysis].